Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 64 results for "yeda research development company"

Rosetta Genomics Announces Next-Generation Sequencing Research Collaboration With Weizmann Institute of Science's Nancy and Stephen Grand Israel National Center for Personalized Medicine
Scottrade

Rosetta Genomics Enters NGS Research Collaboration with Weizma...

Rosetta Genomics , a developer and provider of microRNA-based molecular diagnostics, entered into a collaborative research and license agreement with Yeda Research and Development, the commercial arm of the Weizmann Institute of Science . The ... Genetic Engineering News, 1 month ago
[x]  

111 images for yeda research development company

Drug Discovery and Development, 1 week ago
Abu Dhabi National, 2 days ago
RIA Novosti, 1 week ago
Schott Nexterion AG, 6 days ago
United States Army, 6 days ago
DCMilitary Tester, 1 week ago
Newswise, 1 week ago
DCMilitary Tester, 1 week ago
Investing.com, 2 weeks ago
The Land Australia, 1 day ago

Soligenix expands pipeline with acquisition of Phase III-ready oncology clinical program

Soligenix, a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, has announced that the acquisition of a novel orphan drug candidate, known as SGX301 ...
 Pharmaceutical Business Review6 days ago Soligenix acquires novel orphan drug candidate for treatment of CTCL  News-Medical.Net1 week ago Soligenix acquires Ph III-ready oncology clinical program05-09-2014  Pharma Letter1 week ago
[x]  
Globes

NovaTrans fails to take off

Despite a long list of top-tier investors, the electronics company is struggling to survive. Investing in a start-up is a high-risk investment, but the chance of a glorious exit, or of building a giant company always exists and ignites investors ...
 Globes1 week ago

Researchers Submit Patent Application, "Social Network Based Education Infrastructure and Methods of Implementing and Using Social Network Based...

Researchers Submit Patent Application, "Social Network Based Education Infrastructure and Methods of Implementing and Using Social Network Based Education Infrastructures", for Approval By a News Reporter-Staff News Editor at Politics & Government ...
 HispanicBusiness.com1 month ago
RTTNews.com

ACT Gets Its Act Right, HART Given Privileged Status, FDA Nod Fails To Lift KERX

Actavis plc's (ACT: Quote) New Drug Application for investigational antibiotic Ceftazidime-avibactam, for the treatment of patients with Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI), including those ...
 RTTNews.com1 week ago
IMFA

Meet the magnet-free computer of the future

​ By Rivka Borochov Israelis historically have taken a leading role in amping up the performance and storage capacity of computers. Researchers from Tel Aviv University invented the flash drive or disk-on-key and now researchers at the ...
 IMFA2 weeks ago

CELL SOURCE, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.

The information set forth below should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q, as well as with the financial statements and ...
 HispanicBusiness.com3 weeks ago BIOTIME INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations  TMC Net1 month ago MOMENTA PHARMACEUTICALS INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.  TMC Net1 month ago

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the Introduction of GeneCards PlusTM

New release features powerful tools for registered members ALAMEDA, Calif.--( BUSINESS WIRE )--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneCards ® Version 3.12. The new release is ...
 Business Wire2 months ago BioTime : LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the Introduction of GeneCards Plus  4 Traders2 months ago

CELL SOURCE, INC. FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Changes in Registrant's Certifying Accountant, Unregistered Sale of Equ

Item 1.01 Entry into a Material Definitive Agreement. On June 30, 2014 (the "Closing Date"), Cell Source, Inc. f/k/a Ticket to See, Inc. ("TTSE" or the "Company") entered into and closed a share exchange agreement (the "Share Exchange Agreement") ...
 HispanicBusiness.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less